UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y
Number of items: 332.

A

ARESU, M; Brage, S; Mindell, J; (2009) Physical fitness in adults. (Health Survey for England (2008). Volume 1 Physical activity and fitness ). The Health and Social care Information Centre: Leeds.

Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; Guttman, M; ... Regev, A; + view all (2009) Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses. Science , 326 (5950) pp. 257-263. 10.1126/science.1179050.

Arkenau, ; (2009) Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials (vol 26, pg 5910, 2008). JOURNAL OF CLINICAL ONCOLOGY , 27 (34) p. 5859. 10.1200/JCO.2009.26.9142.

Arkenau, H-T; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; Judson, I; (2009) Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer. ONCOLOGY , 76 (3) pp. 151-156. 10.1159/000195884.

Arkenau, HT; (2009) Capecitabine/oxaliplatin results in outcome similar to infusional 5 FU/leucovorin/oxaliplatin in MCRC: Results of a meta-analysis. American Journal of Hematology/ Oncology , 8 (5)

Averdam, A; Petersen, B; Rosner, C; Neff, J; Roos, C; Eberle, M; Aujard, F; ... Walter, L; + view all (2009) A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates. PLOS GENET , 5 (10) , Article e1000688. 10.1371/journal.pgen.1000688. Green open access
file

Ayaru, L; Stoeber, K; Webster, GJ; Hatfield, ARW; Wollenschlaeger, A; Williams, G; Pereira, SP; (2009) DIAGNOSIS OF PANCREATICOBILIARY MALIGNANCY BY DETECTION OF MINICHROMOSOME MAINTENANCE PROTEIN 5 IN BILIARY BRUSH CYTOLOGY SPECIMENS. In: GUT. (pp. A25 - A25). B M J PUBLISHING GROUP

B

BBC, NO; (2009) Thalidomide lung cancer 'failure'. UNSPECIFIED

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. Epigenetics , 4 (4) pp. 248-254.

Balasubramaniam, T; Johnson, R; Cwynarski, K; Ackroyd, S; El-Sharkawi, D; Ashcroft, J; McNamara, C; ... Moreton, P; + view all (2009) Treatment outcomes of primary CNS lymphoma with IDARAM chemotherapy regime. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 14 - 14). WILEY-BLACKWELL PUBLISHING, INC

Balbi, KJ; Rocha, EPC; Feil, EJ; (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol , 26 (2) pp. 345-355. 10.1093/molbev/msn252.

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Barber, PR; Ameer-Beg, SM; Gilbey, J; Carlin, LM; Keppler, M; Ng, TC; Vojnovic, B; (2009) Multiphoton time-domain fluorescence lifetime imaging microscopy: Practical application to protein-protein interactions using global analysis. In:

Barrowcliffe, TW; Chandler, WL; Favaloro, EJ; Gardiner, C; Goodeve, A; Gray, E; Jennings, I; ... others, ; + view all (2009) Dorothy M. Adcock MD. In: UNSPECIFIED John Wiley & Sons

Bartlett, JMS; Campbell, FM; Ibrahim, M; Thomas, J; Wenyck, I; Ellis, IO; Kay, E; ... Miller, K; + view all (2009) A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech (TM) HER2 FISH probe. In: CANCER RESEARCH. (pp. 206S - 206S). AMER ASSOC CANCER RESEARCH

Bartlett, JMS; Campbell, FM; Ibrahim, M; Wencyk, P; Ellis, I; Kay, E; Connolly, Y; ... Miller, K; + view all (2009) Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH. AM J CLIN PATHOL , 132 (4) 514 - 520. 10.1309/AJCPXY3MJ6GSRCYP.

Bartlett, JMS; Miller, K; (2009) HER2: Closing the Gap Between Laboratory Testing and Clinical Practice Reply. AM J CLIN PATHOL , 131 (6) 898 - 899.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; ... Hurley, CK; + view all (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. pp. 971-981.

Bazeos, A; Marin, D; Gerrard, G; Szydlo, R; Milojkovic, D; Reid, A; de Lavallade, H; ... Khorashad, JS; + view all (2009) BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1258). AMER SOC HEMATOLOGY

Beck, S; (2009) Reverse Phenotyping: Towards an integrated (epi)genomic approach to complex phenotypes and common disease. In: JOURNAL OF MEDICAL GENETICS. (pp. S31 - S31). B M J PUBLISHING GROUP

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. GENOME MEDICINE , 1 (ARTN 56) 10.1186/gm56.

Bell, CG; Wood, DR; Cheong, SJH; Kwan, E; Sinosich, M; Delprado, W; Baumgart, KW; (2009) Molecular confirmation of pathological specimen integrity in Australasia. Pathology , 41 (3) pp. 280-283. 10.1080/00313020902756311.

Berro, M; Mayor, NP; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2009) TGFB1 codon 10 polymorphism: Impact on outcome in allogeneic unrelated donor hematopoietic stem cell transplantation. In: TISSUE ANTIGENS. (pp. 488 - 488). WILEY-BLACKWELL PUBLISHING, INC

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Black, E; Glasspool, DW; Grando, MA; Patkar, V; Fox, J; (2009) Goal-Based Decisions for Dynamic Planning. In: Combi, C and Shahar, Y and AbuHanna, A, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 96 - 100). SPRINGER-VERLAG BERLIN

Boffa, MC; Cohen, H; Tincani, A; (2009) Diagnostic criteria for the obstetric antiphospholipid syndrome. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Boshoff, C; Posner, M; (2009) Targeting EGFR in head and neck cancer: a decade of progress. NAT CLIN PRACT ONCOL , 6 (3) 123 - 123. 10.1038/ncponc1328.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; Gale, RE; ... Med Res Council Adult Leukaemia Wo, ; + view all (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Bradshaw, TD; Stevens, MFG; Calvert, H; Plummer, ER; (2009) Preliminary clinical experiences of Phortress: Putative role for c-MET inhibition in antitumor activity. In: AMER ASSOC CANCER RESEARCH

Bridgewater, J; Valle, J; Palmer, D; Cunningham, D; Anthoney, D; Maraveyas, A; Hughes, S; ... Wasan, H; + view all (2009) Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): final results of the UK ABC-02 trial. In: EJC SUPPLEMENTS. (pp. 361 - 361). PERGAMON-ELSEVIER SCIENCE LTD

Brown, ACN; Hallouane, D; Mawby, WJ; Karet, FE; Saleem, MA; Howie, AJ; Toye, AM; (2009) RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels. Am J Physiol Renal Physiol , 296 (6) F1279-F1290. 10.1152/ajprenal.00013.2009.

Brown, NW; Hiwarkar, P; Shaw, BE; Kulkarni, S; Saso, R; Evans, S; Treleaven, J; ... Tredger, JM; + view all (2009) Mycophenolic Acid Concentration Monitoring for Mycophenolate Mofetil-treated Graft versus Host Disease. In: THERAPEUTIC DRUG MONITORING. (pp. 663 - 663). LIPPINCOTT WILLIAMS & WILKINS

Bruce, AW; Lopez-Contreras, AJ; Flicek, P; Down, TA; Dhami, P; Dillon, SC; Koch, CM; ... Vetrie, D; + view all (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. GENOME RES , 19 (6) 994 - 1005. 10.1101/gr.089086.108.

Bucciarelli-Ducci, C; Lyne, J; Reyes, E; Assomull, R; Petryka, J; Watkins, S; Gatehouse, P; ... Pennell, D; + view all (2009) Diagnostic Performance of Perfusion Cardiovascular Magnetic Resonance Compared With Gated Myocardial Perfusion SPECT in Patients With Known or Suspected Coronary Artery Disease. In: CIRCULATION. (pp. S1094 - S1094). LIPPINCOTT WILLIAMS & WILKINS

C

CRT, ; Stoeber, K; Williams, GH; (2009) Diagnostic, predictive and prognostic testing for cancer. WO/2009/050461.

Cantu, C; Ierardi, R; Fugazza, C; Grande, V; Alborelli, I; Ottolenghi, S; Ferrari, G; (2009) SOX6 OVEREXPRESSION IN HUMAN ERYTHROID PROGENITORS STRONGLY ENHANCES THEIR TERMINAL MATURATION. In: (Proceedings) 38th Annual Scientific Meeting of the ISEH-Society-for-Hematology-and-Stem-Cells. (pp. S12-S12). ELSEVIER SCIENCE INC

Carle, D; Bielack, S; Sydes, M; Butterfass-Bahloul, T; Calaminus, G; Jovic, G; Marina, N; ... Bernstein, M; + view all (2009) The European and American Osteosarcoma Study Group protocol EURAMOS 1: Successful transatlantic cooperation in osteosarcoma. In:

Chacko, S; Taskapan, H; Roscoe, J; Stein, J; Woods, E; Denton, T; Ting, R; ... Sikaneta, T; + view all (2009) Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature. Clin Nephrol , 72 (5) pp. 414-417.

Chaffe, B; Jones, J; Milkins, C; Taylor, C; Asher, D; Glencross, H; Murphy, M; ... Collaborative, UKTL; + view all (2009) UK transfusion laboratory collaborative: recommended minimum standards for hospital transfusion laboratories. Transfusion medicine , 19 pp. 156-158.

Chan, CF; Gatehouse, PD; Hughes, R; Roughton, M; Pennell, DJ; Firmin, DN; (2009) Novel Technique Used to Detect Swallowing in Volume-Selective Turbo Spin-Echo (TSE) for Carotid Artery Wall Imaging. J MAGN RESON IMAGING , 29 (1) 211 - 216. 10.1002/jmri.21607.

Chanalaris, A; Grace, C; Gale, R; Linch, D; Nacheva, EP; (2009) GENOME PROFILING OF NORMAL KARYOTYPE AML WITH HIGH DENSITY ARRAY COMPARATIVE GENOME HYBRIDISATION. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 114 - 114). FERRATA STORTI FOUNDATION Gold open access

Cheung, CW; Khwaja, A; (2009) Stromal cell-mediated drug resistance in acute myeloid leukaemia (AML) is attenuated by PI103, a dual inhibitor of Class I PI3-Kinase (PI3K) and mTOR. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM; (2009) Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature , 460 (7251) pp. 123-127. 10.1038/nature08087.

Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, S-F; Stein, RC; Ellis, IO; ... Edwards, PAW; + view all (2009) The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. ONCOGENE , 28 (46) pp. 4041-4052. 10.1038/onc.2009.259.

Coccia, M; Brooks, SP; Webb, TR; Christodoulou, K; Wozniak, IO; Murday, V; Balicki, M; ... Hardcastle, AJ; + view all (2009) X-linked cataract and Nance-Horan syndrome are allelic disorders. Hum Mol Genet , 18 (14) pp. 2643-2655.

Cohen, H; (2009) Anticoagulation: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, London.

Cohen, H; (2009) Effectively implementing the NPSA safety alert. [Lecture]. Presented at: Institute of healthcare management conference on medication errors, London.

Cohen, H; (2009) Late obstetric morbidity in antiphospholipid syndrome. Presented at: VII European Forum on antiphospholipid antibodies, Marseilles.

Cohen, H; (2009) SHOT data 2008 Part 1. [Lecture]. Presented at: SHOT annual symposium, Royal Society of Medicine, London.

Cohen, H; Baglin, T; (2009) Plasma, plasma products and indications for their use. In: Contreras, M, (ed.) ABC of transfusion medicine: british medical journal books. (pp. 40-47). Wiley-Blackwell

Cohen, H; Gates, C; (2009) Anticoagulation therapy: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, Manchester.

Cohen, H; Gates, C; (2009) Anticoagulation with dabigatran or rivaroxaban. Drugs and Therapeutics Bulletin , 47 pp. 116-120.

Cohen, H; Gates, C; (2009) New oral agents vs subcutaneous alternatives. Has the DTB drawn the correct conclusion? BMJ online

Collins, GP; Paterson, JC; Campbell, L; Mason, DY; Enver, T; Marafioti, T; (2009) EXPRESSION AND EPIGENETIC ANALYSIS OF KEY B-LINEAGE TRANSCRIPTIONAL PROGRAMMES IN HODGKIN/REED-STERNBERG CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 36). FERRATA STORTI FOUNDATION Gold open access

Cooley, S; Guethlein, L; Trachtenberg, E; Ladner, M; Luo, X; Le, CT; Wang, T; ... Miller, JS; + view all (2009) Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. pp. 277-278). AMER SOC HEMATOLOGY

Cooley, S; Parham, P; Trachtenberg, E; Luo, X; Le, CT; Klein, J; Marsh, SGE; ... Miller, JS; + view all (2009) THE RELAPSE-FREE SURVIVAL BENEFIT ASSOCIATED WITH GROUP B KIR HAPLOTYPE DONORS FOR UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION IS UNIQUE TO ACUTE MYELOGENOUS LEUKEMIA. In: (Proceedings) Tandem Meeting on Biology of Blood and Marrow Transplantation. (pp. p. 3). ELSEVIER SCIENCE INC

Cowie, MR; Nicol, ED; Fittall, B; Roughton, M; Cleland, JGF; Dargie, H; (2009) Heart failure in the UK Reply. HEART , 95 (2) 156 - 157.

Cunningham, D; Sirohi, B; Pluzanska, A; Utracka-Hutka, B; Zaluski, J; Glynne-Jones, R; Koralewski, P; ... Cassidy, J; + view all (2009) Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. ANNALS OF ONCOLOGY , 20 (2) pp. 244-250. 10.1093/annonc/mdn638.

Cybulla, M; Walter, KN; Schwarting, A; DiVito, R; Feriozzi, S; Sunder-Plassmann, G; (2009) Kidney transplantation in patients with Fabry disease. TRANSPLANT INTERNATIONAL , 22 (4) pp. 475-481. 10.1111/j.1432-2277.2008.00824.x.

D

Dalby, M; Kharbanda, R; Ghimire, G; Spiro, J; Moore, P; Roughton, M; Lane, R; ... Ilsley, C; + view all (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. AM HEART J , 158 (5) 829 - 835. 10.1016/j.ahj.2009.08.012.

Dancey, G; Begent, RH; Meyer, T; (2009) Imaging in targeted delivery of therapy to cancer. TARGET ONCOL , 4 (3) 201 - 217. 10.1007/s11523-009-0119-8.

Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; Othman, S; ... McNamara, C; + view all (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) near miss reporting. In: (Proceedings) British society for haematology annual scientific meeting.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) reports relating to anti-D immunoglobulin. In: (Proceedings) British society for haematology annual scientific meeting.

Davis, R; Sielaff, A; Ruprich, J; Westrate, L; Tronrud, C; Ferguson, A; Brown, T; ... Lee, M; + view all (2009) Design, synthesis, biophysical and biological studies of fluorescent Hoechst-polyamide hybrid molecules. ABSTR PAP AM CHEM S , 237 ? - ?.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; Galy, A; ... Svinartchouk, F; + view all (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) pp. 3666-3676. 10.1002/pmic.200800747.

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. J Clin Oncol , 27 (15_suppl) , Article e15650.

Dignan, FL; Anthias, C; Ethell, ME; Morilla, R; Morilla, A; Davies, FE; Morgan, GJ; ... Shaw, BE; + view all (2009) The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia. In: BLOOD. (pp. 1020 - 1021). AMER SOC HEMATOLOGY

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; Treleaven, JG; ... Potter, MN; + view all (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

Ding, XY; Patel, M; Shen, DF; Herzlich, AA; Cao, XG; Villasmil, R; Klupsch, K; ... Chan, CC; + view all (2009) Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration. INVEST OPHTH VIS SCI , 50 (10) 4957 - 4966. 10.1167/iovs.09-3381.

Dovey, CL; Aslanian, A; Sofueva, S; Yates, JR; Russell, P; (2009) Mms1-Mms22 complex protects genome integrity in Schizosaccharomyces pombe. DNA REPAIR , 8 (12) 1390 - 1399. 10.1016/j.dnarep.2009.09.008.

Dulev, S; de Renty, C; Mehta, R; Minkov, I; Schwob, E; Strunnikov, A; (2009) Essential global role of CDC14 in DNA synthesis revealed by chromosome underreplication unrecognized by checkpoints in cdc14 mutants. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (34) pp. 14466-14471. 10.1073/pnas.0900190106.

Dunn, JM; Fullarton, G; Thorpe, S; Novelli, M; Bown, SG; Lovat, LB; (2009) RADIOFREQUENCY ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS AFTER FAILED PHOTODYNAMIC THERAPY: FIRST RESULTS OF THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. In: (pp. PT286-).

Dunn, JM; Fullarton, GM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation of High Grade Dysplasia in Barrett's Oesophagus Is Safe and Effective After Failed Photodynamic Therapy - First Results of the UK HALO RFA Registry. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB260 - AB260). MOSBY-ELSEVIER

Dunn, JM; Mackenzie, GD; Oukrif, D; Green, SJ; Chew, Y; Mosse, CA; Thorpe, S; ... Lovat, L; + view all (2009) DNA Ploidy As a Prognostic Biomarker After Ala Photodynamic Therapy for High Grade Dysplasia in Barrett's Oesophagus. In: GASTROENTEROLOGY. (pp. A49 - A49). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; ... Lovat, LB; + view all (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A111 - A112). B M J PUBLISHING GROUP

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; ... Lovat, LB; + view all (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. In: (pp. PT285-).

Dunn, JM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation for the Treatment of Squamous High Grade Dysplasia of the Oesophagus- First Reported Series. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB255 - AB255). MOSBY-ELSEVIER

de Bono, JS; Brunetto, A; Kristeleit, RS; Mais, A; Hauns, B; Hentsch, B; (2009) Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor. European journal of cancer , 7 (2) p. 137.

de Fabiani, E; Gilardi, F; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; Caruso, D; ... Marinovich, M; + view all (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. In: GLIA. (pp. S51 - S51). WILEY-LISS

E

Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) pp. 2-6. 10.1016/j.bbmt.2008.10.013.

El-Mehidi, N.S.; (2009) Bayesian network models of interdependent chromosomal aberrations in unstable cancer genomes. Doctoral thesis , UCL (University College London).

Ella, W; Short, SC; (2009) Using retinoids to increase radio-iodine uptake in thyroid cancer: role as potential redifferentiation agents. In: The handbook on iodine. Elsevier

Endrighi, R; Hamer, M; O'Donnell, K; Steptoe, A; (2009) Optimism is associated with lower daily cortisol production in healthy older men and women. PSYCHOLOGY & HEALTH , 24 pp. 163-164.

Essafi, A; Gomes, AR; Pomeranz, KM; Zwolinska, AK; Varshochi, R; McGovern, UB; Lam, EW-F; (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol Biol , 462 pp. 201-211. 10.1007/978-1-60327-115-8_13.

Everington, T.; (2009) Investigation of the molecular and functional pathophysiology of polycythaemia vera. Doctoral thesis , UCL (University College London).

F

FOLEY, JH; NESHEIM, ME; (2009) Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis , 7 (3) pp. 453-459. 10.1111/j.1538-7836.2008.03261.x.

Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fazel, MZ; Gogalniceanu, P; Patel, A; Capitano, A; Kocjan, G; Falzon, M; Douek, M; (2009) Intra-operative touch imprint cytology for assessing sentinel lymph nodes in patients with lobular breast cancer. In: CANCER RESEARCH. (pp. 108S - 108S). AMER ASSOC CANCER RESEARCH

Fern, L; Ashton, J; Broonan, K; Irving, C; Millington, H; Starkey, C; Wright, D; (2009) Involving young people with cancer in research. The National Cancer Research Institute’s Teeange and Young Adult Core Consumer Group – a new and evolving model. In:

Fong, LY; Wan, SG; Taccioli, C; Jiang, YB; Liu, XP; Croce, CM; Farber, JL; (2009) Zinc Deficiency Induces Upregulation of S100A8/A9 and Abolishes the Anticancer Effects of COX-2 Disruption in Murine Oral-Esophageal Cancer Prevention. J NUTRIGENET NUTRIGE , 2 (4-5) 211 - 211.

Foroni, L; Gerrard, G; Nna, E; Khorashad, JS; Stevens, D; Swale, B; Milojkovic, D; ... Marin, D; + view all (2009) Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY , 84 (8) pp. 517-522. 10.1002/ajh.21457.

Francis, RE; Myatt, SS; Krol, J; Hartman, J; Peck, B; McGovern, UB; Wang, J; ... Lam, EW-F; + view all (2009) FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol , 35 (1) pp. 57-68.

G

GUPTA, R; Vyas, P; Enver, T; (2009) Molecular targeting of cancer stem cells. Cell Stem Cell , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

Gancheva, K; Postadjian, A; Brazma, D; Grace, C; Chanalaris, A; Nacheva, E; Apostolova, MD; (2009) COPY NUMBER VARIANTS: DISTRIBUTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS. BIOTECHNOL BIOTEC EQ , 23 (1) 1095 - 1100.

Gardiner, C; Machin, S; Mackie, I; (2009) Point-of-Care Testing in Hemostasis. In: Quality in Laboratory Hemostasis and Thrombosis. (pp. 72-80).

Gaya, A.M.; (2009) Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P). Doctoral thesis , UCL (University College London). Green open access
file

Gennarino, VA; Sardiello, M; Avellino, R; Meola, N; Maselli, V; Anand, S; Cutillo, L; ... Banfi, S; + view all (2009) MicroRNA target prediction by expression analysis of host genes. pp. 481-490.

George, S; Lal, R; Camidge, DR; Arkenau, H; Chick, J; Poondru, S; Yap, TA; ... Scurr, M; + view all (2009) Final results of a dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of two schedules of OSI-930 in patients (pts) with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. EUROPEAN JOURNAL OF PHARMACOLOGY , 609 (1-3) pp. 34-39. 10.1016/j.ejphar.2009.03.018.

Ghimire, G; Spiro, J; Kharbanda, R; Roughton, M; Barlis, P; Mason, M; Ilsley, C; ... Dalby, M; + view all (2009) Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention , 4 (4) pp. 481-484.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS<sup>©</sup>-YG study. European Journal of Oncology Nursing , 13 (3) pp. 187-192. 10.1016/j.ejon.2009.03.004.

Gibson, F; Pearce, S; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) CANCER IN YOUNG PEOPLE: A NARRATIVE STUDY TO EXPLORE THEIR EXPERIENCE FROM FIRST SYMPTOMS TO THE DIAGNOSIS OF CANCER. In: PEDIATR BLOOD CANCER. (pp. 751 - 751). WILEY-LISS

H

Haas, TL; Emmerich, CH; Gerlach, B; Schmukle, AC; Cordier, SM; Rieser, E; Feltham, R; ... Walczak, H; + view all (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell , 36 pp. 831-844. 10.1016/j.molcel.2009.10.013.

Hackshaw, A; (2009) Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer. Expert Opinion on Pharmacotherapy , 10 (16) pp. 1-7.

Hackshaw, A; (2009) A concise guide to clinical trials. [Book]. (1st ed.). BMJ Books (Blackwell & John Wiley Publishing)

Hackshaw, A; (2009) The NCRI prospective randomised trial of high (standard) versus low dose 131I ablation with or without recombinant TSH (HiLo). In: Miles, A, (ed.) The effective management of head, neck and thyroid cancer. UK Key Advances in Clinical Practice. Aesculapius Medical Press (In press).

Hackshaw, AK; Mallick, U; (2009) Low versus high I-131 dose for remnant ablation in differentiated thyroid cancer. Clinical Medicine and Research , 7 (1/2) pp. 1-3.

Hall, JRAS; SC, ; (2009) Management of Glioblastoma Multiforme in HIV patients: a case series and review of published studies. Clinical Oncology

Harland, SJ; Welch, R; Huddart, R; Stenning, S; Pollock, P; Gabe, R; (2009) On the necessity for postchemotherapy surgery for residual abdominal masses in metastatic nonseminomatous germ cell tumors (NSGCT) of testis. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Hatton, C; Peniket, A; Tusold, A; Collins, G; Joyner, M; Lee, R; Mouncey, P; (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting/British Society for Haematology, Brighton.. (pp. 13-). British Journal of Haematology

Hewish, M; Miller, R; Forster, MD; Smith, IE; (2009) Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV-exposure prophylaxis: a case report. Journal of Medical Case Reports , 3 8866-.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; Oscier, D; ... Pocock, C; + view all (2009) An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). In: BLOOD. (pp. 1331 - 1332). AMER SOC HEMATOLOGY

Hochhauser, D; Meyer T, L; P, S; V J, C; M, B; R H, W; J, C; ... D, ; + view all (2009) Phase I study of the DNA minor groove binding pyrrolobenzodiazepine dimer (SJG 136) administered every 21 days in patients with advanced solid tumours. Clinical Cancer Research , 15 (6) pp. 2140-2147.

Holmes, AM; Reed, MC; Baker, RJ; Jeevaratnam, P; Mehta, AB; Hughes, DA; (2009) Changes in left ventricular posterior wall thickness after treatment with enzyme replacement therapy and effect upon the Mainz Severity Score Index in patients with Fabry disease. Presented at: UNSPECIFIED.

Holmes, MV; Mehta, A; Morgan, MY; (2009) Hemiparesis in a 36 year old man. BMJ (Online) , 338 (7691) 419-. 10.1136/bmj.b90.

Howard, PW; Chen, Z; Gregson, SJ; Masterson, L; Tiberghien, AC; Cooper, N; Fang, M; ... Thurston, DE; + view all (2009) Synthesis of a novel C2/C2?-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate. Biorganic and Medicinal Chemistry Letters , 19 (22) pp. 6463-6466. 10.1016/j.bmcl.2009.09.012.

Hughes, D; (2009) The Management of Gaucher Disease as a Chronic Disorder. In: CLINICAL THERAPEUTICS. (pp. S182 - S182). ELSEVIER

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

Hughes, DA; Deegan, PB; Barba Romero, M-A; Giugliani, R; (2009) RESPONSES OF FEMALES WITH FABRY DISEASE TO ERT: COMPARISON WITH MALES, USING DATA FROM FOS - THE FABRY OUTCOME SURVEY. Presented at: 11th International Conference of Inborn Errors of Metabolism, San Diego, CA.

I

Iatan, I; Bailey, D; Hafiane, A; Zanesi, N; Taccioli, C; Abu Odeh, M; Pajukanta, P; ... Genest, J; + view all (2009) Deficiency of the WW Domain-Containing Oxidoreductase (WWOX) Impairs the HDL Biogenesis Pathway. In: CIRCULATION. (pp. S476 - S477). LIPPINCOTT WILLIAMS & WILKINS

Isgro, G; Colvaruso, V; Manousou, P; Luong, TV; Andreana, L; Patch, DW; Davies, N; ... Burroughs, AK; + view all (2009) CORRELATION OF ISHAK STAGE,TRANSIENT ELASTOGRAPHY,HVPG AND COLLAGEN PROPORTIONATE AREA IN HCV TRANSPLANTED PATIENTS. In: HEPATOLOGY. (pp. 481A - 482A). JOHN WILEY & SONS INC

J

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; ... National Cancer Research Institute (NCRI) ACT II Trial Managemen, ; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (18_suppl) LBA4009-.

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; ... National Cancer Research Institute (NCRI) ACT II Trial Managemen, ; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (15_suppl) LBA4009-.

Janczar, S; Graham, J; Paige, A; Gabra, H; (2009) Targeting locoregional peritoneal dissemination in ovarian cancer. Expert Review of Obstetrics & Gynecology , 4 (2) pp. 133-147. 10.1586/17474108.4.2.133.

K

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia (Nature Clinical Practice Endocrinology and Metabolism (2009) 5, (101-112) DOI: 10.1038/ncpendmet1046). Nature Clinical Practice Endocrinology and Metabolism , 5 (3) 180-. 10.1038/ncpendmet1096.

Kapur, A; Hall, RJ; Qureshi, AC; Malik, IS; Flather, M; Roughton, M; Beatt, KJ; (2009) COMPARISON OF BARE METAL STENTS VERSUS DRUG-ELUTING STENTS IN PATIENTS WITH MULTIVESSEL DISEASE AND DIABETES: RESULTS FROM A CARDIA TRIAL SUBSTUDY. In: HEART. (pp. A7 - A8). B M J PUBLISHING GROUP

Kaput, J; Cotton, RG; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; ... Yeom, YI; + view all (2009) Planning the human variome project: the Spain report. pp. 496-510.

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 15A-15A). NATURE PUBLISHING GROUP

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA REPLICATION LICENSING FACTORS AND ANEUPLOIDY ARE LINKED TO TUMOUR CELL CYCLE STATES AND CLINICAL OUTCOME IN PENILE CARCINOMA. EUR UROL SUPPL , 8 (4) 368 - 368.

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA replication licensing factors and aneuploidy are linked to tumour cell cycle states and clinical outcome in penile carcinoma. In: (Proceedings) 24th Annual EAU Congress. (pp. p. 368). Elsevier

Keenan, NG; Grasso, A; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Firmin, DN; (2009) Comparison of 2D and multislab 3D magnetic resonance techniques for measuring carotid wall volumes (vol 28, pg 1476, 2008). J MAGN RESON IMAGING , 29 (6) 1493 - 1493. 10.1002/jmri.21771.

Keenan, NG; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Hooper, J; Firmin, DN; (2009) Magnetic resonance of carotid artery ageing in healthy subjects. ATHEROSCLEROSIS , 205 (1) 168 - 173. 10.1016/j.atherosclerosis.2008.11.018.

Kelleher, MT; Fruhwirth, G; Patel, G; Ofo, E; Festy, F; Barber, PR; Ameer-Beg, SM; ... Ng, T; + view all (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol , 4 (3) pp. 235-252. 10.1007/s11523-009-0116-y.

Ketchell, RI; Roughton, M; Agent, P; Gyi, K; Hodson, ME; (2009) Predicting survival in end-stage cystic fibrosis. RESP MED , 103 (10) 1441 - 1447. 10.1016/j.rmed.2009.04.025.

Khorashad, JS; Wagner, S; Greener, L; Marin, D; Reid, A; Milojkovic, D; Patel, H; ... Foroni, L; + view all (2009) The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 94 (6) pp. 861-864. 10.3324/haematol.2008.003715.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; Puga, AC; (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; Salomoni, P; ... Tavassoli, M; + view all (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. ONCOGENE , 28 (39) 3499 - 3512. 10.1038/onc.2009.191.

Knight, SJL; Akha, ES; Timbs, A; Enver, T; Pettitt, AR; Taylor, J; Hatton, CS; (2009) Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 451). AMER SOC HEMATOLOGY

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; Smith, P; ... Wilson, P; + view all (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Krishnamurthy, S; Shaw, BE; Byrne, J; Seedhouse, C; Mayor, N; Madrigal, JA; Russell, N; (2009) A caspase8 promoter polymorphism is associated with increased TRM and reduced survival following T-cell depleted unrelated donor transplantation using alemtuzumab. In: BONE MARROW TRANSPLANTATION. (pp. S79 - S80). NATURE PUBLISHING GROUP

Kristeleit, R; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. J Clin Oncol , 27 (15_suppl) 2566-.

Kristeleit, R; O'Brien, M; (2009) Cardiotoxicity from cytotoxics in the 21st century. British Journal of Cardiology , 16 (2) pp. 60-62.

Kristeleit, RS; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. Journal of Clinical Oncology , 27 (15S)

Kulkarni, AA; Kingsbury, SR; Tudzarova, S; Hong, HK; Loddo, M; Rashid, M; Rodriguez-Acebes, S; ... Williams, GH; + view all (2009) Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma. CLIN CANCER RES , 15 (7) 2417 - 2425. 10.1158/1078-0432.CCR-08-1276.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT, ; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.

Kyriakou, C; Canals, C; Finke, J; Kobbe, G; Harousseau, J-L; Kolb, H-J; Novitzky, N; ... Schmitz, N; + view all (2009) Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol , 27 (24) pp. 3951-3958. 10.1200/JCO.2008.20.4628.

L

Lacombe, T; Garcia-Gomez, JJ; de la Cruz, J; Roser, D; Hurt, E; Linder, P; Kressler, D; (2009) Linear ubiquitin fusion to Rps31 and its subsequent cleavage are required for the efficient production and functional integrity of 40S ribosomal subunits. MOLECULAR MICROBIOLOGY , 72 (1) pp. 69-84. 10.1111/j.1365-2958.2009.06622.x.

Lambert, J; Linch, DC; Gale, RE; (2009) MULTIPLE JAK2 V617F MUTATIONS ARE PRESENT IN MOST PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A NEW DISEASE PARADIGM. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 421 - 421). FERRATA STORTI FOUNDATION Gold open access

Lambert, JR; Everington, T; Linch, DC; Gale, RE; (2009) In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. BLOOD , 114 (14) 3018 - 3023. 10.1182/blood-2009-03-209916.

Lawrenson, K; Benjamin, E; Turmaine, M; Jacobs, I; Gayther, S; Dafou, D; (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. CELL PROLIFERAT , 42 (3) 385 - 393. 10.1111/j.1365-2184.2009.00604.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35-. 10.1186/1472-6750-9-35.

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; ... Temple, G; + view all (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; ... Temple, G; + view all (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). J Clin Oncol , 27 (15_suppl) 5501-.

Ledermann, JA; Stebbing, J; (2009) Positioning pemetrexed in the treatment of ovarian cancer. EUR J CANCER , 45 (8) 1330 - 1332. 10.1016/j.ejca.2009.02.006.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Lee, SM; Hackshaw, A; (2009) Correspondence. Response: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomised, double-blind, placebo-controlled trial. Journal of the National Cancer Institute

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; Spiro, S; ... Hackshaw, A; + view all (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) pp. 1049-1057. 10.1093/jnci/djp200. Green open access

Leitner, S; Sweeney, K; Oberg, D; Davies, D; Miranda, E; Lemoine, NR; Hallden, G; (2009) Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research , 15 (5) pp. 1730-1740. 10.1158/1078-0432.CCR-08-2008.

Lhériteau, E; Libeau, L; Stieger, K; Deschamps, J-Y; Mendes-Madeira, A; Provost, N; Lemoine, F; ... Rolling, F; + view all (2009) The RPGRIP1-deficient dog, a promising canine model for gene therapy. Mol Vis , 15 pp. 349-361.

Liu, J; Lu, X; Drummond, C; Hutton, C; Jackson, J; Bennaceur, K; Newell, D; ... Lunec, J; + view all (2009) Mechanisms of cellular resistance to the growth inhibitory and cytotoxic effects of MDM2-p53 binding antagonists. In: AMER ASSOC CANCER RESEARCH

Loddo, M; Kingsbur, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El Sheikh, S; ... Williams, GH; + view all (2009) Cell cycle phase progression analysis identifies unique replication phenotypes of major prognostic and predictive significance in cancer. In: CANCER RESEARCH. (pp. 320S - 320S). AMER ASSOC CANCER RESEARCH

Lolkema, MP; Harrington, K; Evans, J; Arkenau, HT; Roxburgh, P; Morrison, R; Roulstone, V; ... de Bono, J; + view all (2009) A phase-I study of the combination of intravenous reovirus (REOLYSIN (R)) and gemcitabine in patients with advanced cancer. In: (Proceedings) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology. (pp. p. 131). PERGAMON-ELSEVIER SCIENCE LTD

Lowdell, MW; Morris, E; (2009) Recent advances in clinical cellular immunotherapy. In: Practical Transfusion Medicine: Third Edition. (pp. 462-468).

Lowe, HL; Sharma, SK; Bagshawe, KD; Chester, KA; (2009) Antibody directed enzyme prodrug therapy (ADEPT). In: Recombinant Antibodies for Immunotherapy. (pp. 336-349).

M

Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Mahendran, AO; Elvey, M; Mahendran, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES DIRECTLY INFLUENCE PATIENT MANAGEMENT. TRANSPLANT INTERNATIONAL , 22 p. 16.

Mahendran, AO; Haroon, S; Dupont, PJ; Howie, A; Veitch, PS; (2009) AN INCREMENTAL INCREASE IN CHRONIC ALLOGRAFT DAMAGE DETECTED ON PROTOCOL BIOPSIES DURING THE FIRST YEAR POST-TRANSPLANTATION. TRANSPL INT , 22 260 - 260.

Majumder, B; Lowdell, M; Smith, C; Rakhit, RD; (2009) Differential expression of local versus systemic platelet-monocyte complexes in the circulation of patients with acute coronary syndrome. In: (pp. pp. 197-198). OXFORD UNIV PRESS

Makrogianneli, K; Carlin, LM; Keppler, MD; Matthews, DR; Ofo, E; Coolen, A; Ameer-Beg, SM; ... Ng, T; + view all (2009) Integrating receptor signal inputs that influence small Rho GTPase activation dynamics at the immunological synapse. Mol Cell Biol , 29 (11) pp. 2997-3006. 10.1128/MCB.01008-08.

Malladi, R; Sloane-Stanley, J; Gupta, R; Rodrigues, N; Wood, W; Enver, T; (2009) THE EFFECT OF THE TEL-TRKC ONCOGENE ON THE HAEMATO-ENDOTHELIAL DIFFERENTIATION FROM HUMAN EMBRYONIC STEM CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 2). FERRATA STORTI FOUNDATION Gold open access

Manousou, P; Arvaniti, V; Tsochatzis, E; Germani, G; Rolando, N; Pleguezuelo, M; Jones, K; ... Burroughs, AK; + view all (2009) RECURRENCE PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION: THE EFFECT OF AZATHIOPRINE. In: JOURNAL OF HEPATOLOGY. (pp. S180 - S180). ELSEVIER SCIENCE BV

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. EXPERT REVIEW OF HEMATOLOGY , 2 (2) pp. 133-136. 10.1586/EHM.09.3.

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; ... Linch, DC; + view all (2009) Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. J CLIN ONCOL , 27 (26) 4352 - 4356. 10.1200/JCO.2009.22.0996.

Marelli, L; Shusang, V; Buscombe, JR; Cholongitas, E; Stigliano, R; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2009) Transarterial Injection of I-131-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer. JOURNAL OF NUCLEAR MEDICINE , 50 (6) pp. 871-877. 10.2967/jnumed.108.060558.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update April 2009. TISSUE ANTIGENS , 74 (3) pp. 272-275. 10.1111/j.1399-0039.2009.01322.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update August 2008. TISSUE ANTIGENS , 73 (1) pp. 91-92. 10.1111/j.1399-0039.2008.01165.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update February 2009. TISSUE ANTIGENS , 74 (2) pp. 180-182. 10.1111/j.1399-0039.2009.01285.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update July 2008. TISSUE ANTIGENS , 73 (1) pp. 88-90. 10.1111/j.1399-0039.2008.01164.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update June 2009. TISSUE ANTIGENS , 74 (4) pp. 364-366. 10.1111/j.1399-0039.2009.01330.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update March 2009. TISSUE ANTIGENS , 74 (2) pp. 183-186. 10.1111/j.1399-0039.2009.01288.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update October 2008. TISSUE ANTIGENS , 73 (4) pp. 381-382. 10.1111/j.1399-0039.2009.01211.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update September 2008. TISSUE ANTIGENS , 73 (1) pp. 93-94. 10.1111/j.1399-0039.2008.01169.x.

Marthandan, N; Karp, DR; Amett, F; Waller, MJ; Guidry, P; Feolo, M; Marsh, SGE; (2009) HLA genetic association analysis using the sequence feature variant type approach. JOURNAL OF IMMUNOLOGY , 182

Martin-Berenjeno, I; Vanhaesebroeck, B; (2009) PI3K Regulatory Subunits Lose Control in Cancer. CANCER CELL , 16 (6) pp. 449-450. 10.1016/j.ccr.2009.11.017.

Mattar, CN; Dighe, NM; Waddington, SN; McIntosh, J; Biswas, A; Fisk, NM; Davidoff, AM; ... Chan, J; + view all (2009) Long-Term Transgene Expression in New-Born Cynomolgus Macaques Following Intra-Uterine Gene Transfer of Self-Complementary AAV. In: MOLECULAR THERAPY. (pp. S117 - S117). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: TISSUE ANTIGENS. (pp. 403 - 403). WILEY-BLACKWELL PUBLISHING, INC

McCabe, DJH; Starke, R; Harrison, P; Brown, MM; Sidhu, PS; Mackie, IJ; Machin, SJ; (2009) ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 103 - 104). B M J PUBLISHING GROUP

McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A; (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene , 28 (11) pp. 1465-1470. 10.1038/onc.2008.483.

McClelland, B; Cohen, H; McClelland, B; (2009) Risks of transfusion in the context of haemovigilance: SHOT - the UK haemovigilance system. In: ABC of transfusion medicine: british medical journal books. (pp. 83-88). Wiley-Blackwell

McCormack, M; Ledermann, J; Hall-Craggs, M; Symonds, P; Warwick, V; Fernando, I; Hackshaw, A; (2009) Phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: (Proceedings) ASCO. (pp. A5586-).

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. J Clin Oncol , 27 (15_suppl) 5586-.

McDonald, V; Scully, M; Manns, K; Mackie, IJ; Machin, SJ; (2009) Serum rituximab levels in TTP: the effect of plasma exchange and correlation with response to treatment. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McGovern, UB; Francis, RE; Peck, B; Guest, SK; Wang, J; Myatt, SS; Krol, J; ... Lam, EW-F; + view all (2009) Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther , 8 (3) pp. 582-591. 10.1158/1535-7163.MCT-08-0805.

McGovern, UB; Stebbing, J; (2009) Receptor-based predictors of response in breast cancer. [Editorial comment]. Future Oncology , 5 (3) 283 - 286. 10.2217/fon.09.1. Green open access
file

Mehta, A; (2009) Eighth International Symposium on Lysosomal Storage Diseases. International Journal of Clinical Pharmacology and Therapeutics , 47 (supp 1) S1-S3.

Mehta, A; (2009) Psychosocial aspects of Fabry disease and their impact on optimal disease management. Clinical Therapeutics , 31 s1-s2.

Mehta, A; Clarke, JTR; Giugliani, R; Elliott, P; Linhart, A; Beck, MS-PG; (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survery. Journal of Medical Genetics , 46 pp. 548-552. 10.1136/jmg.2008.065904.

Mehta, A; Hoffbrand, A; (2009) Haematology at a Glance. [Book]. (3rd ed.). Blackwell Wiley

Mehta, AB; (2009) Anderson – Fabry Disease : developments in diagnosis and therapy. International Journal of Clinical Pharmacology and Therapeutics , 47 (1) s66-s74.

Mehta, AB; (2009) Common hereditary lysosomal storage disorders. BMJ Point of Care

Meng, S; Arbit, T; Veeriah, S; Mellinghoff, IK; Fang, F; Vivanco, I; Rohle, D; (2009) 14-3-3 sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. CELL CYCLE , 8 (14) pp. 2238-2246. 10.4161/cc.8.14.8998.

Meyer, T; (2009) Interventional Radiological Treatment of Liver Tumours. British Journal of Cancer , 100 p. 1975.

Meys, R; Fowles, F; Little, A; Marsh, SG; Asboe, D; Hawkins, DA; Gotch, FM; (2009) Immunogenetics of HIV associated HPV disease after HAART. In: (Proceedings) 69th Annual Meeting of the Society-of-Investigative-Dermatology. (pp. S82-S82). NATURE PUBLISHING GROUP

Miene, C; Klenow, S; Veeriah, S; Richling, E; Glei, M; (2009) Impact of apple polyphenols on GSTT2 gene expression, subsequent protection of DNA and modulation of proliferation using LT97 human colon adenoma cells. MOLECULAR NUTRITION & FOOD RESEARCH , 53 (10) pp. 1254-1262. 10.1002/mnfr.200800444.

Miller, K; Ibrahim, M; Herriot, K; (2009) The UK NEQAS online auditing system for breast cancer predictive markers. VIRCHOWS ARCH , 455 75 - 75.

Mischerikow, N; Spedale, G; Altelaar, AFM; Timmers, HTM; Pijnappel, WWMP; Heck, AJR; (2009) In-depth profiling of post-translational modifications on the related transcription factor complexes TFIID and SAGA. J Proteome Res , 8 (11) pp. 5020-5030. 10.1021/pr900449e.

Mohamedbhai, SG; Lowry, L; Goldstone, AH; Linch, DC; Ardeshna, KM; (2009) Rituximab in combination with CODOX-M/IVAC: toxicity and efficacy in 17 adults with non-HIV related B-cell non-Hodgkin lymphomas with 495% proliferation index. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 16). WILEY-BLACKWELL PUBLISHING, INC

Moore, P; Barlis, P; Spiro, J; Ghimire, G; Roughton, M; Di Mario, C; Wallis, W; ... Dalby, M; + view all (2009) A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents. JACC-CARDIOVASC INTE , 2 (5) 437 - 444. 10.1016/j.jcin.2009.01.010.

Morris, EC; Thomson, KJ; (2009) Bone marrow and stem cell transplantation. Medicine , 37 (3) pp. 168-171. 10.1016/j.mpmed.2009.01.001.

Morris, T; Oakervee, H; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; ... Cavenagh, J; + view all (2009) The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. CLINICAL LYMPHOMA & MYELOMA , 9 S27-S27.

Mulder, K; Westrate, L; Brown, T; Mackay, H; Chavda, S; Babu, B; Wilson, D; ... Lee, M; + view all (2009) DNA sequence selective recognition by the pyrrole(H)/N-methylpyrrole and pyrrole(H)/N-methylimidazole: Design, synthesis, and biophysical characteristics. ABSTR PAP AM CHEM S , 238 ? - ?.

Murugaesu, N; Powles, T; Bestwick, J; Oliver, RTD; Shamash, J; (2009) Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis. Osteoporos Int , 20 (9) pp. 1627-1630. 10.1007/s00198-008-0793-x.

N

Napoli, I; Noon, LA; Parrinello, S; White, I; Woodhoo, A; Lloyd, AC; (2009) RAF/ERK SIGNALLING IN SCHWANN CELLS IS SUFFICIENT TO INDUCE SCHWANN CELL DEDIFFERENTIATION IN VIVO. In: GLIA. (pp. S159 - S159). WILEY-LISS

Ng, T; Boguslavsky, SK; Tarcic, G; Wakim, J; Kiuchi, T; Liu, A; Reinitz, F; (2009) An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis. Current Biology , 19 (21) pp. 1788-1798. 10.1016/j.cub.2009.09.048.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability (Part 1): Coronary Angiography. J COMPUT ASSIST TOMO , 33 (2) 161 - 168.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability, Part 2: Global and Regional Ventricular Function, Mass, and First Pass Perfusion. J COMPUT ASSIST TOMO , 33 (2) 169 - 174.

Nikitenko, LL; (2009) Vascular endothelium in cancer. CELL TISSUE RES , 335 (1) 223 - 240. 10.1007/s00441-008-0707-4.

Novakovic, B.; Sibson, M.; Ng, H.K.; Manuelpillai, U.; Rakyan, V.; Down, T.; Beck, S.; ... Saffery, R.; + view all (2009) Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. Journal of Biological Chemistry , 284 (22) pp. 14838-14848. 10.1074/jbc.M809542200. Green open access
file

O

Observer, ; (2009) Smoking is a childhood addiction. Protect our children-vote to put tobacco out of sight.

Ogilvie, R; Plaunt, A; Riddering, C; Westrate, L; Davis, R; Ferguson, A; Chavda, S; ... Lee, M; + view all (2009) ORGN 339-Design, synthesis and DNA binding properties of orthogonally positioned diamino-containing polyamides. ABSTR PAP AM CHEM S , 237 ? - ?.

Olmos, D; Brunetto, A; Ang, J; Tan, D; Sandhu, S; Kristeleit, R; Lolkelma, M; ... Kaye, S; + view all (2009) 1257 Retrospective analysis of unplanned hospital admissions: an early surrogate indicator of patient (pt) attrition in phase-I trials. European Journal of Cancer Supplements , 7 (2) pp. 137-138. 10.1016/S1359-6349(09)70469-0.

Olmos, D; Brunetto, A; Ang, J; Tan, D; Sandhu, S; Kristeleit, R; Lolkelma, M; ... Kaye, S; + view all (2009) Retrospective analysis of unplanned hospital admissions: an early surrogate indicator of patient (pt) attrition in phase-I trials. In: (Proceedings) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology. (pp. pp. 137-138). PERGAMON-ELSEVIER SCIENCE LTD

Ors, A; Grimaldi, M; Kimata, Y; Wilkinson, CR; Jones, N; Yamano, H; (2009) The transcription factor Atf1 binds and activates the APC/C ubiquitin ligase in fission yeast. J. Biol. Chem. , 284 (36) pp. 23989-23994. Gold open access

P

Pacey, SC; Wilson, R; Walton, M; Eatock, M; Zetterlund, A; Arkenau, H; Beecham, R; ... Judson, I; + view all (2009) A phase I trial of the HSP90 inhibitor, alvespimycin (17-DMAG) administered weekly, intravenously, to patients with advanced, solid tumours. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Pankhurst, T; Lepenies, J; Nightingale, P; Howie, AJ; Adu, D; Harper, L; (2009) Vasculitic IgA nephropathy: prognosis and outcome. Nephron Clin Pract , 112 (1) c16-c24. 10.1159/000210570.

Parrinello, S; Noon, L; Harrisingh, M; Digby, PW; Parada, L; Lloyd, A; (2009) NF1 LOSS DISRUPTS SCHWANN CELL-AXONAL INTERACTIONS: A NOVEL ROLE FOR SEMAPHORIN 4F. In: GLIA. (pp. S43 - S43). WILEY-LISS

Pastores, GM; Giraldo, P; Cherin, PMA; (2009) Goal-orientated therapy with Miglustat in Gaucher disease. Current Medical Research and Opinion , 25 (1) pp. 23-37. 10.1185/03007990802576518.

Patel, B; Buck, G; Mortuza, Y; Rai, L; Mitchell, W; Gerrard, G; Hoffbrand, AV; ... Foroni, L; + view all (2009) Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993. BRITISH JOURNAL OF HAEMATOLOGY , 145 p. 44.

Patel, B; Ghorani, E; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, A; Fielding, AK; (2009) Attenuated Measles Virus: A Promising Therapeutic Modality for B Cell Malignancy. In: BLOOD. (pp. 970 - 970). AMER SOC HEMATOLOGY

Patel, B; Goldstone, AH; Fielding, AK; (2009) Allogeneic Stem Cell Transplantation for acute lymphoblastic leukaemia (ALL). In: Lazarus, H and Laughlin, M, (eds.) Allogeneic Stem Cell Transplantation. Humana Pr Inc

Patel, BR; Thompson, J; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, AJ; Fielding, AK; (2009) Differential Effect of Measles Virus Oncolysis in B Cell Malignancies. In: (Proceedings) 12th Annual Meeting of the American Society of Gene Therapy. (pp. S158-S158). NATURE PUBLISHING GROUP

Paten, B; Herrero, J; Beal, K; Birney, E; (2009) Sequence progressive alignment, a framework for practical large-scale probabilistic consistency alignment. BIOINFORMATICS , 25 (3) pp. 295-301. 10.1093/bioinformatics/btn630.

Paterson, AL; Provenzano, E; O Donovan, M; Davies, SE; Novelli, MR; Lovat, LB; Fitzgerald, RC; (2009) ERBB2 EXPRESSION IN OESOPHAGEAL ADENOCARCINOMA AND BARRETT’S OESOPHAGUS: DEMONSTRATING THE POTENTIAL FOR A PRE-EMPTIVE STRIKE. In: (pp. PT283-).

Paulussen, M; Craft, A; Lewis, I; Hackshaw, A; Douglas, C; Whelan, J; Jurgens, HFDEICESSSG; (2009) Zwei randomisierte Ewing Sarkom Studien Schweizer Krebsbulletin. Bulletin suisse du cancer , 29 (2) pp. 128-134.

Paulussen, M; Craft, AW; Lewis, I; Hackshaw, A; Douglas, C; Whelan, J; Jürgens, H; (2009) Zwei randomisierte Ewing Sarkom Studien. Schweizer Krebsbulletin - Bulletin suisse du cancer (Swiss Cancer Bulletin) , 29 (2) pp. 128-134.

Payne, E; Look, T; (2009) Zebrafish modelling of leukaemias. Br J Haematol , 146 (3) pp. 247-256. 10.1111/j.1365-2141.2009.07705.x.

Pearce, S; Gibson, F; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) The experiences of young people from first symptoms to the diagnosis of cancer: a narrative study. In: (pp. 234-).

Pearce, S; Gibson, F; Eden, TE; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) A narrative study of the experiences of young people from first symptoms to the diagnosis of cancer. In:

Peggs, KS; Krauss, A; Mackall, C; (2009) Clinical implications of immune reconstitution following autologous and allogeneic transplantation. In: Bishop, MR, (ed.) Hematopoietic Stem Cell Transplantation. (pp. 131-154). Springer Verlag

Peggs, KS; Quezada, SA; Sharma, P; Allison, JP; (2009) Cancer immunotherapy. In: Hong, WK and Bast, RC and Hait, W and Kufe, DW and Pollock, RE and Holland, JF and Weichselbaum, RR, (eds.) Cancer medicine 8. (pp. 175-189). Pmph USA Ltd

Pellagatti, A; Marafioti, T; Paterson, JC; Malcovati, L; Della Porta, MG; Jadersten, M; Pushkaran, B; ... Boultwood, J; + view all (2009) Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY , 146 (1) pp. 86-90. 10.1111/j.1365-2141.2009.07720.x.

Perera, G; Kassen, D; Nestle, F; (2009) A successful therapeutic model for psoriasis: recapitulation of human psoriasis in a xenotransplantation mouse model. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 10 - 10). WILEY-BLACKWELL PUBLISHING, INC

Perera, GK; Kassen, D; Nestle, FO; (2009) Investigation of the spatiotemporal expression pattern of the antimicrobial peptide, LL-37, in the development and resolution of psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 904 - 904). WILEY-BLACKWELL PUBLISHING, INC

Peters, FH; Brunell, C; Benjamin, E; (2009) Massive ovarian edema and contralateral mature cystic teratoma: asymptomatic presentation in a premenarchal female. J Pediatr Adolesc Gynecol , 22 (5) e118-e120. 10.1016/j.jpag.2008.09.005.

Plummer, R; Coronado, C; Massard, C; Calvert, AH; Margetts, J; Bahleda, R; Prados, R; ... Soria, J-C; + view all (2009) Phase I, open-label, dose-escalating clinical and pharmacokinetic study of PM00104 administered weekly resting every fourth week, intravenously, over 1 hour to patients with advanced malignant solid tumors or lymphoma. In: AMER ASSOC CANCER RESEARCH

Plummer, R; Hayward, L; Lorigan, P; Soriano, V; Moiseyenko, V; Szyldergemajn, S; Prados, R; ... Calvert, H; + view all (2009) Plitidepsin alone or with dacarbazine (DTIC) as first-line treatment for advanced unresectable melanoma (AUM). J Clin Oncol , 27 (15_suppl) 9059-.

Privitera, A; Milkhu, CS; Datta, V; Rodriguez-Justo, M; Windsor, A; Cohen, CR; (2009) Actinomycosis of the sigmoid colon: A case report. World Journal of Gastrointestinal Surgery , 1 (1) 62 - 64. 10.4240/wjgs.v1.i1.62. Green open access
file

Puccio, I; (2009) Evaluation of FasL/CD95L apoptosis marker in the course of Multiple Sclerosis. Presented at: Antel Regional Congress ECM “ New reality and prospects of Biomedical Laboratory Technician",, At Cinisi( Pa) Sicily- Italy.

Q

Querol, S; Rubinstein, P; Marsh, SGE; Goldman, J; Madrigal, JA; (2009) Cord blood banking: 'providing cord blood banking for a nation'. BRITISH JOURNAL OF HAEMATOLOGY , 147 (2) pp. 227-235. 10.1111/j.1365-2141.2009.07818.x.

Quinn, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2009) A Monoclonal Antibody for Detection of Folylpolyglutamate Synthetase in Paraffin Embedded Tissues. HYBRIDOMA , 28 (6) 415 - 421. 10.1089/hyb.2009.0040.

Quinn, J; Rabin, N; Rodriguez-Justo, M; Choi, D; Yong, K; (2009) Multiple myeloma presenting with spinal cord compression during pregnancy. ANN HEMATOL , 88 (2) 181 - 182. 10.1007/s00277-008-0558-9.

Quinn, J; Rabin, N; Rodriguez-Justo, M; Choi, D; Yong, K; (2009) Multiple myeloma presenting with spinal cord compression during pregnancy. pp. 181-182.

Quinn, J; Von Klemperer, K; Brooks, R; Peebles, D; Walker, F; Cohen, H; (2009) Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. HAEMATOL-HEMATOL J , 94 (11) 1608 - 1612. 10.3324/haematol.2008.002840. Gold open access

R

Rahim, AA; Wong, AM; Buckley, SM; Hughes, DA; Karlsson, S; Cooper, JD; Thrasher, AJ; ... Waddington, SN; + view all (2009) Fetal Gene Therapy for Acute Neuronopathic Gaucher Disease. In: MOLECULAR THERAPY. (pp. S357 - S357). NATURE PUBLISHING GROUP

Rahman, KM; Reszka, AP; Gunaratnam, M; Haider, SM; Howard, PW; Fox, KR; Neidle, S; (2009) Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chem Commun (Camb) (27) 4097 - 4099. 10.1039/b902359c.

Razak, ARA; Nutt, JE; O'Toole, K; Black, F; Plummer, ER; Calvert, AH; Lunec, J; (2009) Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis. Lung Cancer , 63 82-.

Reiss, U; Davidoff, A; Gray, J; Nienhuis, A; Nathwani, A; (2009) Dose response results of self complementary adeno-associated virus (AAV) vector-mediated factor IX gene transfer in non-human primates. HAEMOPHILIA , 15 (2) 635 - 635.

Ringland, CL; Arkenau, HT; O'Connell, DL; Ward, RL; (2009) Second primary colorectal cancers (SPCRCs): Experiences from a large Australian cancer registry. Annals of Oncology , 21 (1) pp. 92-97. 10.1093/annonc/mdp288.

Robinson, J; Roberts, CH; Dodi, IA; Madrigal, JA; Pawelec, G; Wedel, L; Marsh, SGE; (2009) The European searchable tumour line database. CANCER IMMUNOLOGY IMMUNOTHERAPY , 58 (9) pp. 1501-1506. 10.1007/s00262-008-0656-5.

Robinson, J; Waller, MJ; Fail, SC; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2009) The IMGT/HLA database. D1013-D1017.

Roddie, C; Paul, J; Benjamin, R; Gallimore, C; Xerry, J; Gray, JJ; Peggs, K; ... Ward, K; + view all (2009) Allogeneic haematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognised cause of morbidity. In: BONE MARROW TRANSPLANTATION. (pp. S63 - S63). NATURE PUBLISHING GROUP

Roddie, C; Peggs, K; (2009) Hodgkin’s Lymphoma. Medicine , 37 (4) pp. 208-211.

Rodriguez-Mateos, M; Abia, D; Garcia-Gomez, JJ; Morreale, A; de la Cruz, J; Santos, C; Remacha, M; (2009) The amino terminal domain from Mrt4 protein can functionally replace the RNA binding domain of the ribosomal P0 protein. NUCLEIC ACIDS RESEARCH , 37 (11) pp. 3514-3521. 10.1093/nar/gkp209.

Rodriguez-Mateos, M; Garcia-Gomez, JJ; Francisco-Velilla, R; Remacha, M; de la Cruz, J; Ballesta, JPG; (2009) Role and dynamics of the ribosomal protein P0 and its related trans-acting factor Mrt4 during ribosome assembly in Saccharomyces cerevisiae. NUCLEIC ACIDS RESEARCH , 37 (22) pp. 7519-7532. 10.1093/nar/gkp806.

Ryland, JK; Lawrie, AS; Machin, SJ; Mackie, IJ; (2009) Persistent high factor VIII activity leading to increased thrombin generation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 4 - 4). WILEY-BLACKWELL PUBLISHING, INC

S

Salomoni, P; (2009) Stemming out of a new PML era? CELL DEATH DIFFER , 16 (8) 1083 - 1092. 10.1038/cdd.2009.63.

Salomoni, P; Michod, D; (2009) End of the Daxx diatribe? CELL CYCLE , 8 (10) 1467 - 1468.

Sandhu, J; Kaur, B; Armstrong, C; Talbot, CJ; Steward, WP; Farmer, PB; Singh, R; (2009) Determination of 5-methyl-2'-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci , 877 (20-21) pp. 1957-1961. 10.1016/j.jchromb.2009.05.032.

Schellekens, J; Schaffer, M; Roberts, CH; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2009) KIR3DL1 allele typing by sequence-based typing. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 36 (5) p. 316.

Schellekens, J; Schaffer, M; Roberts, CH; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2009) KIR3DL1 allele typing by sequencing-based typing analysis. In: (Proceedings) 23rd European Immunogenetics and Histocompatibility Conference. (pp. pp. 456-457). WILEY-BLACKWELL PUBLISHING, INC

Schuh, AH; Knight, SJL; SadighiAkha, E; Enver, T; Taylor, J; (2009) IDENTIFICATION OF NOVEL RECURRENT COPY NUMBER VARIATIONS BY HIGH RESOLUTION COMPARATIVE GENOME HYBRIDISATION. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 136). FERRATA STORTI FOUNDATION Gold open access

Shalaby, AAE; Presneau, N; Idowu, BD; Thompson, L; Briggs, TRW; Tirabosco, R; Diss, TC; (2009) Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. MODERN PATHOL , 22 (8) 996 - 1005. 10.1038/modpathol.2009.63.

Shaw, BE; Apperley, J; Russell, NH; Craddock, CF; Liakopoulou, E; Potter, MN; Wynn, R; ... Byrne, JL; + view all (2009) A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC. In: BLOOD. (pp. 495 - 496). AMER SOC HEMATOLOGY

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; ... Madrigal, JA; + view all (2009) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia

Shaw, BE; Veys, P; Pagliuca, A; Addada, J; Cook, G; Craddock, CF; Gennery, AR; ... Hough, RE; + view all (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant. , 44 (1) pp. 7-12.

Short, SC; (2009) Re-irradiation of brain tumours-evidence, indications and limitations. In: (pp. pp. 410-411).

Siddle, H.V.; Deakin, J.E.; Coggill, P.; Hart, E.; Cheng, Y.; Wong, E.S.W.; Harrow, J.; ... Belov, K.; + view all (2009) MHC-linked and un-linked class I genes in the wallaby. BMC Genomics , 10 (1) , Article 310. 10.1186/1471-2164-10-310. Green open access
file

Silvanto, A; Novelli, M; Lovat, L; (2009) SIRT – an uncommon cause of gastroduodenal ulceration. Histopathology , 55 (1) 114 - 115. 10.1111/j.1365-2559.2009.03333.x.

Singh, KJDAL; O'Hare, MJ; Pizzey, A; Appasammy, M; Stein, RC; Muttukrishna, S; (2009) Ovarian Granulosa Cells Have Varying Sensitivity to Different Cytotoxic Drugs Used To Treat Young Breast Cancer Patients. In: (Proceedings) 56th Annual Meeting of the Society-for-Gynecologic-Investigation. (pp. 151A-151A). SAGE PUBLICATIONS INC

Spiegelberg, BGI; Sewell, MD; Coltman, T; Blunn, GW; Flanagan, AM; Cannon, SR; Briggs, TWR; (2009) Below-knee amputation through a joint-sparing proximal tibial replacement for recurrent tumour. J BONE JOINT SURG BR , 91B (6) 815 - 819. 10.1302/0301-620X.91B6.21577.

Srirajaskanthan, R; Dancey, G; Hackshaw, A; Luong, T; V, C; M, M; T, ; (2009) Circulating Angiopoietin-2 is elevated in NETs and correlates with disease burden and progression. Endocrine-Related Cancer , 16 (3) pp. 967-976.

Srirajaskanthan, R; Desai, K; Jayaratnam, A; Carras, E; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Uncommon sites for metastasis of neuroendocrine tumor in adults. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

Srirajaskanthan, R; Desai, K; Jayaratnam, A; Carras, E; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Uncommon sites for metastasis of neuroendocrine tumor in adults. J Clin Oncol , 27 (15_suppl) , Article e15683.

Srirajaskanthan, R; McStay, M; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review. Neuroendocrinology , 89 (1) pp. 48-55. 10.1159/000151222.

Srirajaskanthan, R; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 29 (11) pp. 1143-1154. 10.1111/j.1365-2036.2009.03988.x.

Stavridi, F; Kristeleit, R; Forster, M; Ang, J-E; Rudman, S; Uttenreuther-Fischer, M; Pemberton, K; ... Spicer, J; + view all (2009) Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer. In: (pp. S444-S444). LIPPINCOTT WILLIAMS & WILKINS

Steele, A; Prentice, AG; Chanalaris, A; Hoffbrand, AV; Cwynarski, K; Wickremasinghe, R; (2009) Induction of Noxa Via Generation of Reactive Oxygen Species Plays a Key Role in Induction of CLL Cell Apoptosis by Two Novel p53-Independent Cytotoxic Agents. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1076). AMER SOC HEMATOLOGY

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2009) 2-phenylacetylenesulphonamide induces p53-independent apoptosis of CLL cells via upregulation of the BH3 protein Noxa. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) pp. 1217-1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) pp. 1217-1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamide(PAS) induces p53-independent killing of B-chronic lymphocytic leukemia(CLL) cells. Blood , 114 (6) pp. 1217-1225.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; North, JM; Nacheva, EP; Chanalaris, A; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamise(PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia cells (CLL) cells. Blood , 114 (6) pp. 1217-1225.

Stephens, HA; Cox, S; Fernando, R; Howie, AJ; Harber, M; Little, A-M; (2009) MICA ANTIBODIES ASSOCIATE WITH BIOPSY-PROVEN CELLULAR REJECTION IN RENAL TRANSPLANT RECIPIENTS. TRANSPLANT INTERNATIONAL , 22 p. 69.

T

Taccioli, C; Fabbri, E; Visone, R; Volinia, S; Calin, GA; Fong, LY; Gambari, R; ... Croce, CM; + view all (2009) UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. NUCLEIC ACIDS RES , 37 D41 - D48. 10.1093/nar/gkn702. Gold open access

Tan, M. H.; Smith, A. J.; Pawlyk, B.; Xu, X.; Liu, X.; Bainbridge, J. B.; Basche, M.; ... Ali, R. R.; + view all (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) pp. 2099-2114. 10.1093/hmg/ddp133. Green open access
file

Taylor, C; Cohen, H; Mold, D; Jones, H; (2009) The 2008 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Thind, A; Freeman, T; Thorpe, C; Burt, A; Stewart, M; (2009) Family physicians' satisfaction with current practice: what is the role of their interactions with specialists? Healthc Policy , 4 (3) e145-e158.

Tirabosco, R; Hing, S; Carlstedt, T; Flanagan, AM; (2009) Intraneural Perineurioma. FISH Assessment of the BCR Locus in 7 Cases. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 24A-24A). NATURE PUBLISHING GROUP

Tobias, J; Monson, K; Gupta, N; MacDougall, H; Glaholm, J; Hutchison, I; Kadalayil, L; (2009) Chemo-radiotherapy for locally advanced head and neck cancer: ten-year follow up of the UK Head and Neck (UKHAN1) trial. Lancet Oncology , 11 pp. 66-74.

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Marelli, L; Singhrao, T; Meyer, T; Buscombe, J; (2009) 90-Yttrium-DOTA-octreotate for the treatment of advanced neuroendocrine tumors. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Marelli, L; Singhrao, T; Meyer, T; Buscombe, J; (2009) 90-Yttrium-DOTA-octreotate for the treatment of advanced neuroendocrine tumors. J Clin Oncol , 27 (15_suppl) 4594-.

Townsend, W; Cross, NCP; Waghorn, K; Somana, K; Ramsay, A; Thomson, K; Peggs, K; (2009) Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder. BONE MARROW TRANSPL , 44 (3) 197 - 199. 10.1038/bmt.2008.448.

U

UCL, SOLMSSN; (2009) Research Focus: Researchers conduct innovative targeted lung cancer trials. SLMS Newsletter September 2009 (5) pp. 8-9.

V

Valle, JW; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; Baka, S; ... Bridgewater, J; + view all (2009) Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01. British Journal of Cancer , 101 (4) pp. 621-627.

Valle, JW; Wasan, HS; Palmer, DD; Cunningham, D; Anthoney, DA; Maraveyas, A; Hughes, SK; ... Bridgewater, JA; + view all (2009) Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial). J Clin Oncol , 27 (15_suppl) 4503-.

Van Cutsem, E; Rivera, F; Berry, S; Kretzschmar, A; Michael, M; DiBartolomeo, M; Mazier, M; ... Cunningham, D; + view all (2009) SAFETY AND EFFICACY OF BEVACIZUMAB (BEV) AND CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM THE BEAT OBSERVATIONAL COHORT STUDY. In: (Proceedings) 11th World Congress on Gastrointestinal Cancer. (pp. p. 18). OXFORD UNIV PRESS

Van Cutsem, E; Rivera, F; Berry, S; Kretzschmar, A; Michael, M; DiBartolomeo, M; Mazier, MA; ... Cunningham, D; + view all (2009) Safety and efficacy of bevacizumab (BEV) and chemotherapy in elderly patients with metastatic colorectal cancer (mCRC): results from the BEAT observational cohort study. In: (Proceedings) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology. (pp. p. 349). PERGAMON-ELSEVIER SCIENCE LTD

Varughese, MA; Ledermann, JA; (2009) Trial design strategies for vascular-targeted therapy of patients with ovarian cancer. Clinical Ovarian Cancer , 2 (1) pp. 24-30. 10.3816/COC.2009.n.003.

Vassileva, V; (2009) Chemotherapy: Predictors of chemotherapy response in advanced CRC. Nature Reviews Clinical Oncology , 6 (5) 245-. 10.1038/nrclinonc.2009.31.

Vassileva, V; (2009) Hematology: Early markers for leukemia. Nature Reviews Clinical Oncology , 6 (5) 245-. 10.1038/nrclinonc.2009.34.

Villegas, SN; Oikonomoulu, I; Morrison, G; Soneji, S; Enver, T; Brickman, J; (2009) Identification of genes expressed in the anterior definitive endoderm. In: (Proceedings) 16th Annual Conference of the International-Society-of-Development-Biologists. (pp. S239-S240). ELSEVIER SCIENCE BV

Virgili, A; Brazma, D; Grace, C; Nacheva, EP; (2009) Deletions of the Normal ABL1 at the Non-Translocated Chromosome 9 in CML Associated with TKI Resistance. In: BLOOD. (pp. 1260 - 1260). AMER SOC HEMATOLOGY

W

Wang, D; Zhang, S; He, F; Zhu, J; Hu, S; Yu, J; (2009) How do variable substitution rates influence Ka and Ks calculations? Genomics Proteomics Bioinformatics , 7 (3) pp. 116-127. 10.1016/S1672-0229(08)60040-6.

Wang, D-P; Wan, H-L; Zhang, S; Yu, J; (2009) γ-MYN: a new algorithm for estimating Ka and Ks with consideration of variable substitution rates. Biology Direct , 4 (1) p. 20. 10.1186/1745-6150-4-20. Gold open access

Ward, NJ; Apolonia, L; Cochrane, M; Buckley, SM; Waddington, SN; Nathwani, AC; Philpott, NJ; ... Thrasher, AJ; + view all (2009) Nonintegrating Lentiviral Vectors for Treatment of Haemophilia B. In: MOLECULAR THERAPY. (pp. S310 - S310). NATURE PUBLISHING GROUP

Wardley, A; McCaffrey, J; Crown, J; Stein, R; Malik, Z; Rea, D; Barrett-Lee, P; (2009) Preliminary Phase II Data Suggest That Entinostat (SNDX275), a Class 1 Selective Histone Deacetylase Inhibitor (HDACi), May Resensitize Breast Cancer Patients Progressing on Aromataste Inhibitor (AI) Therapy to Their AI Therapy. In: (pp. p. 6111).

Wasan, H; Valle, J; Palmer, D; Cunningham, D; Anthony, A; Maraveyas, A; Hughes, S; ... Bridgewater, J; + view all (2009) GEMCITABINE WITH OR WITHOUT CISPLATIN IN PATIENTS (pts) WITH ADVANCED OR METASTATIC BILIARY TRACT CANCER (ABC): RESULTS OF CA19.9 AND QUALITY OF LIFE ANALYSIS FOR THE UK ABC-02 TRIAL. In: ANNALS OF ONCOLOGY. (pp. 9 - 9). OXFORD UNIV PRESS

West, M; Nicholls, K; Mehta, A; Clarke, J; Steiner, R; Beck, M; Barshop, B; ... Mensah, RSR; + view all (2009) Clinical trial summary of agalsidase alfa in kidney dysfunction in Fabry disease. Journal of the American Society of Nephrology

West, M; Nicholls, K; Mehta, A; Clarke, JT; Steiner, R; Beck, M; Barshop, BA; ... Schiffman, R; + view all (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. Journal of the American Society of Nephrology , 20 (5) pp. 1132-1139.

Wetterskog, D; Moshiri, A; Ozaki, T; Uramoto, H; Nakagawara, A; Funa, K; (2009) Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by Delta Np73 in Neuroblastoma. MOLECULAR CANCER RESEARCH , 7 (12) pp. 2031-2039. 10.1158/1541-7786.MCR-08-0501.

Whelan, J; (2009) Managing sarcomas in teenagers and young adults. In: EJC SUPPLEMENTS. (pp. 82 - 82). PERGAMON-ELSEVIER SCIENCE LTD

Widén, A; Rolando, N; Manousou, P; Rolles, K; Davidson, B; Sharma, D; Tuddenham, E; (2009) Anticoagulation after liver transplantation: a retrospective audit and case-control study. Blood Coagul Fibrinolysis , 20 (8) pp. 615-618. 10.1097/MBC.0b013e32832c87c8.

Windsor, R; Strauss, S; Seddon, B; Michelagnoli, M; Labrum, R; Wood, N; Whelan, ; (2009) A pilot pharmacogenomic study of the influence of cytotoxic target and metabolising gene polymorphisms on toxicity and response in osteosarcoma. In:

Windsor, R; Strauss, S; Seddon, B; Whelan, J; (2009) Experimental therapies in Ewing's sarcoma. EXPERT OPIN INV DRUG , 18 (2) 143 - 159. 10.1517/13543780802715784.

Windsor, R; Strauss, S; Seddon, B; Whelan, J; (2009) Experimental therapies in Ewing’s sarcoma. Expert Opin Investig Drugs , 18 (2) 143-59-143-59.

Wright, TG; Singh, VK; Li, JJ; Foley, JH; Miller, F; Jia, Z; Elliott, BE; (2009) Increased production and secretion of HGF α-chain and an antagonistic HGF fragment in a human breast cancer progression model. International Journal of Cancer , 125 (5) pp. 1004-1015. 10.1002/ijc.24364.

Y

Yamano, H; Trickey, M; Grimaldi, M; Kimata, Y; (2009) In vitro assays for the anaphase-promoting complex/cyclosome (APC/C) in Xenopus egg extracts. Methods Mol. Biol. , 545 pp. 287-300.

Ydreborg, M; Dhillon, AP; Burroughs, AK; Lagging, M; Manousou, P; Westin, J; (2009) LIVER HISTOLOGY ONE YEAR POST-TRANSPLANT PREDICTS PROGRESSION OF FIBROSIS AND DEFINES SEVERE HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION. In: HEPATOLOGY. (pp. 546A - 546A). JOHN WILEY & SONS INC

Yovine, A; Casali, P; G, RF; Vermorken, J; Demetri, G; Whelan, JS; Almorin, E; ... Schoffski, P; + view all (2009) Trabectidin 3 hour infusion every 3 weeks in pre-treated advanced sarcoma patients: acompassionate use administration experience. In: (pp. 597-).

This list was generated on Sun Apr 15 02:50:46 2018 BST.